For patients who are significantly overweight -- the path forward to losing it may include a decision between drugs or ...

Abby Luce was tired of always being behind the camera. For years, she’d be the one taking the photos of her groups of friends ...

Research published in Nature determined why obese individuals who lose weight tend to regain the weight over time. Here's how ...

A Cleveland Clinic study shows that patients with obesity and fatty liver-related cirrhosis who had bariatric (weight-loss) ...

Taking a GLP-1 receptor agonist prior to bariatric surgery may not boost long-term weight loss and metabolic benefits, a ...

Perioperative optimization of nutrition leads to lower risks, better outcomes, and improved quality of life for patients.

Experts stress that obesity is a disease, not a lifestyle choice, and call for better access to pharmacological and surgical ...

A RETROSPECTIVE study conducted by Mass General Brigham researchers has found that taking semaglutide before bariatric ...

A retrospective population-based study showed that severe obesity and bariatric surgery independently increased the risk of inflammatory bowel disease.

Neoadjuvant semaglutide before metabolic and bariatric surgery (MBS) is not beneficial in terms of weight loss, ac ...

Blockbuster GLP-1 medications are changing patient care, impacting surgery volumes and reshaping the financial landscape of the healthcare industry.